Thinking Clearly

How GW Pharma Could Use U.S. Patents to Shape the Future of Medical Cannabis

By Bruce Barcott at Leafly

 

  ..."While two federal agencies (the Justice Department and the Department of Health and Human Services) actively prevent Americans from developing cannabis medicine, another agency (the U.S. Patent and Trademark Office) is helping GW Pharma lock up the intellectual property rights to a broad swath of cannabis-derived medicines and techniques." ...